BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16537876)

  • 1. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
    Dupuy DE; DiPetrillo T; Gandhi S; Ready N; Ng T; Donat W; Mayo-Smith WW
    Chest; 2006 Mar; 129(3):738-45. PubMed ID: 16537876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
    Lanuti M; Sharma A; Digumarthy SR; Wright CD; Donahue DM; Wain JC; Mathisen DJ; Shepard JA
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):160-6. PubMed ID: 19154919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
    Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
    Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
    Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
    Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CT Guided Radiofrequency Ablation Followed Intratumoral Chemotherapy 
in the Treatment of Early Stage Non-small Cell Lung Cancer].
    Feng W; Li J; Han S; Tang J; Yao J; Cui Y; Wang C; Chen Z; Li X; Zhi X
    Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):269-78. PubMed ID: 27215455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ; Wee JO; Punglia RS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence.
    Lanuti M; Sharma A; Willers H; Digumarthy SR; Mathisen DJ; Shepard JA
    Ann Thorac Surg; 2012 Mar; 93(3):921-7; discussion 927-88. PubMed ID: 22296982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of CT-guided percutaneous radiofrequency ablation of inoperable patients with stage Ia non-small cell lung cancer: A retrospective cohort study.
    Huang BY; Li XM; Song XY; Zhou JJ; Shao Z; Yu ZQ; Lin Y; Guo XY; Liu DJ; Li L
    Int J Surg; 2018 May; 53():143-150. PubMed ID: 29555533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
    Grieco CA; Simon CJ; Mayo-Smith WW; DiPetrillo TA; Ready NE; Dupuy DE
    J Vasc Interv Radiol; 2006 Jul; 17(7):1117-24. PubMed ID: 16868164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
    Li X; Zhao M; Wang J; Fan W; Li W; Pan T; Wu P
    AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
    Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
    Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
    Koizumi T; Tsushima K; Tanabe T; Agatsuma T; Yokoyama T; Ito M; Kanda S; Kobayashi T; Yasuo M
    Respiration; 2015; 90(1):47-55. PubMed ID: 26044954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
    Bilal H; Mahmood S; Rajashanker B; Shah R
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
    Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Mason D; Murthy S; Rice TW; Mazzone P; Machuzak M; Mekhail T; Videtic GM
    J Thorac Oncol; 2009 Aug; 4(8):976-82. PubMed ID: 19633473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
    Campeau MP; Herschtal A; Wheeler G; Mac Manus M; Wirth A; Michael M; Hogg A; Drummond E; Ball D
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1371-5. PubMed ID: 19250769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer.
    Tanabe T; Koizumi T; Tsushima K; Ito M; Kanda S; Kobayashi T; Yasuo M; Yamazaki Y; Kubo K; Honda T; Kondo R; Yoshida K
    Chest; 2010 Apr; 137(4):890-7. PubMed ID: 19858232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
    Zemlyak A; Moore WH; Bilfinger TV
    J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
    Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.